{"nct_id":"NCT04976192","title":"Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-08-30","start_date_type":"ACTUAL","primary_completion_date":"2024-04-05","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}